Eliem Therapeutics

Last updated: May 04, 2024

Bob Azelby, CEO
Bob Azelby, CEO
Country: USA | Funding: $291.3M (+)

Website: https://www.eliemtx.com/

Eliem Therapeutics plans to treat chronic pain, depression, epilepsy and anxiety with palmitoylethanolamide (PEA) prodrug